Milestones in the development of VPCIR

2010 – 2017

STEP 1

Basic research Aarhus University (AU), Aarhus University Hospital and
Chinese University of Hong Kong (CUHK) on restriction enzymes

STEP 2

Proof of concept in testing for E. coli using restriction enzyme patterns

September 2017
February 2018

STEP 3

Establishment of VPCIR biosciences aps

STEP 4

Submission of VPCIR patent application by AU/CUHK

April 2018
October 2018

STEP 5

Grant at DKK 1.5M
from Innovation Fund Denmark

STEP 6

Development of first-generation assay (Listeria) commences

November 2018
December 2018

STEP 7

Grant at DKK 0.9 M from Novo Nordisk Foundation

STEP 8

Exclusive license agreement between VPCIR and AU/CUHK on use of patent

December 2018
December 2019

STEP 9

Investment by a group of Danish business angels at DKK 1.7 M

STEP 10

EU Commission grants Seal of Excellence to VPCIR biosciences aps

May 2020
December 2020

STEP 11

The group of dedicated business angels, organized in VPCIR Invest ApS decides to increase their commitment and investment level in VPCIR

STEP 13

VPCIR has successfully negotiated a €134.000 loan arrangement with the Danish Vaekstfonden

March 2021
July 2021

STEP 14

VPCIR biosciences have obtained European trademark protection for our disruptive VPCIR technology. We expect to launch the first VPCIR™ products in about 6 months time

STEP 15

VPCIR biosciences launches a webshop offering its first commercial product:
A human topoisomerase 1 (hTOP1) enzyme for laboratory use available now.

October 2021
March 2021

New event 12

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna suprecent.

Our partners

Aarhus University Logo

CUHK

Sign up for our newsletter today!